Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
CNS Spectrums|December 19, 2013
Understanding depot antipsychotics: an illustrated guide to kineticsJonathan M Meyer
The Journal of Clinical Psychiatry|November 26, 2008
Sexual dysfunction in patients treated with atypical antipsychoticsJonathan M Meyer
Schizophrenia Research|November 9, 2023
Making sense of norclozapine levels: 3 clinical axiomsJonathan M Meyer
Clinical Therapeutics|December 28, 2002
Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerabilitySteven G Potkin, Per T Thyrum, Rimal Bera, et al.
Schizophrenia Research|February 19, 2013
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trialAntony Loebel, Josephine Cucchiaro, Kaushik Sarma, et al.
The Journal of Clinical Psychiatry|March 16, 2005
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trialRichard H Weisler, Paul E Keck, Alan C Swann, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 7, 2006
Bone mineral density in male schizophrenia patients: a reviewJonathan M Meyer, David Lehman
Schizophrenia Bulletin|November 30, 2010
Risk factors for ileus in patients with schizophreniaJimmi Nielsen, Jonathan M Meyer
The Journal of Clinical Psychiatry|August 9, 2023
Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom ManagementLeslie Citrome, Jonathan M Meyer
International Clinical Psychopharmacology|December 1, 2005
An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorderRobert M A Hirschfeld, Mariëlle Eerdekens, Amir H Kalali, et al.
Pageof 14